- Home
- UEIC vs ASRT Comparison
UEIC vs ASRT Comparison
Compare UEIC & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UEIC
- ASRT
- Stock Information
- Founded
- UEIC 1986
- ASRT 1995
- Country
- UEIC United States
- ASRT United States
- Employees
- UEIC N/A
- ASRT N/A
- Industry
- UEIC Consumer Electronics/Appliances
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- UEIC Consumer Staples
- ASRT Health Care
- Exchange
- UEIC Nasdaq
- ASRT Nasdaq
- Market Cap
- UEIC 88.0M
- ASRT 79.1M
- IPO Year
- UEIC 1993
- ASRT 1997
- Fundamental
- Price
- UEIC $4.47
- ASRT $0.95
- Analyst Decision
- UEIC Buy
- ASRT Strong Buy
- Analyst Count
- UEIC 2
- ASRT 1
- Target Price
- UEIC $10.00
- ASRT $3.00
- AVG Volume (30 Days)
- UEIC 70.6K
- ASRT 222.4K
- Earning Date
- UEIC 11-06-2025
- ASRT 11-10-2025
- Dividend Yield
- UEIC N/A
- ASRT N/A
- EPS Growth
- UEIC N/A
- ASRT N/A
- EPS
- UEIC N/A
- ASRT N/A
- Revenue
- UEIC $402,518,000.00
- ASRT $117,099,000.00
- Revenue This Year
- UEIC $0.31
- ASRT N/A
- Revenue Next Year
- UEIC $0.05
- ASRT $5.84
- P/E Ratio
- UEIC N/A
- ASRT N/A
- Revenue Growth
- UEIC 4.00
- ASRT N/A
- 52 Week Low
- UEIC $4.26
- ASRT $0.51
- 52 Week High
- UEIC $12.50
- ASRT $1.38
- Technical
- Relative Strength Index (RSI)
- UEIC 34.82
- ASRT 76.35
- Support Level
- UEIC $4.62
- ASRT $0.79
- Resistance Level
- UEIC $4.86
- ASRT $0.83
- Average True Range (ATR)
- UEIC 0.21
- ASRT 0.04
- MACD
- UEIC 0.03
- ASRT 0.01
- Stochastic Oscillator
- UEIC 0.00
- ASRT 88.81
About UEIC Universal Electronics Inc.
Universal Electronics Inc is a United States-based company that principally designs, develops, manufactures, ships, and supports control and sensor technology solutions and a broad line of universal control systems, audio-video (AV) accessories, wireless security, and smart home products that are used by the world's brands in the video services, consumer electronics, security, home automation, climate control and home appliance markets. It generates its total revenue from the United States.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.